tiprankstipranks
Adverum Biotechnologies reports results of two trials of Ixo-vec in AMD
PremiumThe FlyAdverum Biotechnologies reports results of two trials of Ixo-vec in AMD
4M ago
Adverum Biotechnologies price target lowered to $10 from $12 at RBC Capital
Premium
The Fly
Adverum Biotechnologies price target lowered to $10 from $12 at RBC Capital
4M ago
Is ADVM a Buy, Before Earnings?
Premium
Pre-Earnings
Is ADVM a Buy, Before Earnings?
4M ago
Adverum Biotechnologies management to meet with Oppenheimer
PremiumThe FlyAdverum Biotechnologies management to meet with Oppenheimer
6M ago
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
6M ago
Adverum Biotechnologies reports inducement grants under Nasdaq listing rule
Premium
The Fly
Adverum Biotechnologies reports inducement grants under Nasdaq listing rule
6M ago
Adverum Biotechnologies announces FDA RMAT designation for Ixo-vec
PremiumThe FlyAdverum Biotechnologies announces FDA RMAT designation for Ixo-vec
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
8M ago
Adverum Biotechnologies’ Promising AMD Treatment Advances
Premium
Company Announcements
Adverum Biotechnologies’ Promising AMD Treatment Advances
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100